Industry News
Discovery shows genetic causes of rare bone condition
Researchers at the University of Oxford have discovered two new genetic causes of craniosynostosis, a rare bone condition that can inhibit brain growth in children. [ + ]
ResMed revenues up thanks to strong sales
ResMed (ASX:RMD) has seen revenues increase by 13% for the December quarter year on year with a dividend coming in February. [ + ]
World’s smallest spanner puts a new twist on microscopic manipulation
By harnessing laser light’s ability to gently push and pull microscopic particles, researchers have created the fibre-optic equivalent of the world’s smallest spanner. [ + ]
Researchers identify enzyme involved in deadly brain tumours
In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and the malignant tumour glioblastoma multiforme. [ + ]
Cellmid antibodies reduced kidney damage in mice
Cellmid’s (ASX:CDY) anti-midkine antibodies were able to reduce kidney damage and preserve function in an animal model of diabetic nephropathy. [ + ]
Uscom protocol slashed sepsis deaths: study
A Bathurst hospital reduced sepsis-related deaths by 94% by adopting a treatment protocol involving the use of Uscom (ASX:UCM) diagnostics tech, according to a new study. [ + ]
Allied Healthcare closes $4.6m capital raising
Allied Healthcare (ASX:AHZ) will put the $4.6m raised in a placement and SPP towards launching its CardioCel heart patch as well as phase I trials of its DNA vaccine against herpes. [ + ]
Abraxane extends life in advanced pancreatic cancer patients
A phase III trial has shown Celgene’s Abraxane, distributed here by Specialised Therapeutics, has a significant impact on survival in patients with advanced pancreatic cancer. [ + ]
Men more likely than women to commit scientific fraud
Male scientists are far more likely to commit fraud than females and the fraud occurs across the career spectrum, from trainees to senior faculty. [ + ]
Universal Biosensors expecting to launch new diagnostic in 2013
Universal Biosensors (ASX:UBI), in partnership with Siemens, expects to see its blood coagulation product hit the shelves this year, further boosting revenues for the company. [ + ]
Genetics discovery leads to migraine treatment
The discovery of a genetic mutation several years ago has led to a new treatment using vitamin B and folic acid that is proving successful in treating migraines. [ + ]
Scientists pinpoint molecular signals that make some women prone to miscarriage
Scientists have identified molecular signals that control whether embryos are accepted by the womb and appear to function abnormally in women who have suffered repeated miscarriages. [ + ]
Feedback sought on draft National Code of Practice for Chemicals of Security Concern
Australian governments have decided to pursue a voluntary code of practice for businesses that manage, handle or use products containing 11 chemicals identified as having the potential to be used to make homemade explosives. [ + ]
Another European regulatory milestone for pSivida's Iluvien
Spain's regulator has awarded marketing approval to pSivida's (ASX:PVA) Iluvien, leaving just Italy yet to give the treatment the tick ahead of a launch early this year. [ + ]
New path discovered for future generation of glucose-measuring biosensors
CIC bioGUNE researchers have opened a new pathway for the future development of biosensors that enable the measurement of glucose in the blood and are also believed to be reliable with other fluids, such as urine. [ + ]
